These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Prais D; Schonfeld T; Amir J; Pediatrics; 2003 Sep; 112(3 Pt 1):548-52. PubMed ID: 12949282 [TBL] [Abstract][Full Text] [Related]
4. Respiratory Syncytial Virus Bronchiolitis in Children. Smith DK; Seales S; Budzik C Am Fam Physician; 2017 Jan; 95(2):94-99. PubMed ID: 28084708 [TBL] [Abstract][Full Text] [Related]
10. Timing of bronchiolitis hospitalisations and respiratory syncytial virus immunoprophylaxis in non-metropolitan Western Australia. Moore HC; Keil AD; Richmond PC; Lehmann D Med J Aust; 2009 Nov; 191(10):574. PubMed ID: 19912095 [No Abstract] [Full Text] [Related]
11. Bronchiolitis: the new American Academy of Pediatrics guidelines. Corsello G J Chemother; 2007 Oct; 19 Suppl 2():12-4. PubMed ID: 18073171 [TBL] [Abstract][Full Text] [Related]
12. Current respiratory syncytial virus prevention strategies in high-risk infants. Weisman LE Pediatr Int; 2002 Oct; 44(5):475-80. PubMed ID: 12225544 [TBL] [Abstract][Full Text] [Related]
13. Acute viral bronchiolitis in South Africa: Strategies for management and prevention. Zar HJ; Madhi SA; White DA; Masekela R; Risenga S; Lewis H; Feldman C; Morrow B; Jeena P S Afr Med J; 2016 Apr; 106(4):27-9. PubMed ID: 27303780 [TBL] [Abstract][Full Text] [Related]
14. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile? Hashmi NA; Cosgrove JF; MacMahon P Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917 [TBL] [Abstract][Full Text] [Related]
15. [Chemoprophylaxis with palivizumab in Andalusia (Spain). Results of the 2000-2001 respiratory syncytial virus epidemic]. Grupo de Hospitales Benazuza An Esp Pediatr; 2002 Apr; 56(4):293-7. PubMed ID: 11927095 [TBL] [Abstract][Full Text] [Related]
16. Bronchiolitis in Infants and Children. Schaller A; Galloway CS S D Med; 2017 Jun; 70(6):274-277. PubMed ID: 28813765 [TBL] [Abstract][Full Text] [Related]
17. A review of palivizumab and emerging therapies for respiratory syncytial virus. Shadman KA; Wald ER Expert Opin Biol Ther; 2011 Nov; 11(11):1455-67. PubMed ID: 21831008 [TBL] [Abstract][Full Text] [Related]
18. High rate of indigenous bronchiolitis and palivuzumab. Whitehall JS; Bolisetty S; Whitehall JP; Francis F; Norton R; Patole SK J Paediatr Child Health; 2001 Aug; 37(4):416-7. PubMed ID: 11547779 [No Abstract] [Full Text] [Related]
19. New strategies for control of respiratory syncytial virus infection. Nokes JD; Cane PA Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532 [TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus: how, why and what to do. Rodriguez R; Ramilo O J Infect; 2014 Jan; 68 Suppl 1():S115-8. PubMed ID: 24171820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]